Follicle centre lymphoma follicular grade I II III

6 total trials 2 recruiting MedDRA PT

Filter these 6 trials by phase, country, sponsor and more.

Open in Search →

A Study of Zanubrutinib Versus Lenalidomide in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (MAHOGANY) Recruiting

2022-502548-12-00 5 2023-09-28 "marginal zone lymphoma"
A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 5 2024-02-01 "Follicular lymphoma"
A randomized, open-label, multi-center phase III trial comparing tisagenlecleucel to standard of care in adult participants with relapsed or … Recruitment ended

2023-503452-27-00 5 2024-01-02 "Adult patients with follicular B-cell non-Hodgkin lymphoma g"
Phase II multicenter clinical trial: Mosunetuzumab for early relapse of follicular lymphoma in the Nordic countries (MERLIN/NLG-FL6/ML43841) Recruitment ended

2022-500100-21-01 4 2023-09-11 "Follicular lymphoma"
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previo … Recruitment ended

2024-511747-25-00 4 2019-12-23 "B-cell non-Hodgkin lymphoma (NHL)"
ROLLOVER STUDY FOR TAZEMETOSTAT Ended

2023-510553-41-00 9 2016-08-29 "Subjects will receive tazemetostat as dictated in their ante"

Showing 1–6 of 6 trials